On Monday, 2nd of February 2026, 2:00 PM (Ljubljana/Berlin time), Dr. Shady Sayed from the Department of Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany will present his work titled “Application of CRISPR base editors in innovative cancer therapies” as part of the CTGCT Science Talks webinar series.
Fill up the form to register and receive the link to the webinar on the day of the talk.
Dr Shady Sayed obtained his PhD in 2021, focusing on the identification, inactivation and correction of cancer driver mutations using the CRISPR-Cas9 system. His work included the precise correction of mutations in the KRAS oncogene and TP53 tumor suppressor and identified a novel cancer-driving mutation in UTP14A through CRISPR screening. He is currently a postdoctoral researcher in the group of Prof. Dr. Frank Buchholz at the Faculty of Medicine Carl Gustav Carus, TU Dresden. Additionally, he is a Fellow of the National Translational Tandem Program for Gene- and Cell-based Therapies (nTTP-GCT), coordinated by the Biomedical Innovation Academy of the Berlin Institute of Health at Charité and funded by the Federal Ministry of Education and Research (BMBF). His tandem project is called: “Pioneering molecular surgery with CRISPR-technologies for personalized lung cancer therapy”.
The webinar will be recorded and it might be shared only partially or fully.